Quote | Aequus Pharmaceuticals Inc. (TSXVC:AQS:CC)
Last: | $0.065 |
---|---|
Change Percent: | -13.33% |
Open: | $0.07 |
Close: | $0.065 |
High: | $0.07 |
Low: | $0.065 |
Volume: | 14,501 |
Last Trade Date Time: | 05/06/2022 04:55:12 pm |
News | Aequus Pharmaceuticals Inc. (TSXVC:AQS:CC)
Aequus Pharmaceuticals Inc. (AQS:CA) is expected to report for Q1 2024
(TheNewswire) VANCOUVER, May 09, 2024 – TheNewswire – Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company focused on bringing healthcare solutions to Canadians through licens...
Message Board Posts | Aequus Pharmaceuticals Inc. (TSXVC:AQS:CC)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Aequus Pharmaceuticals Inc. Company Name:
AQS:CC Stock Symbol:
TSXVC Market:
Aequus Pharmaceuticals Inc. (AQS:CA) is expected to report for Q1 2024
(TheNewswire) VANCOUVER, May 09, 2024 – TheNewswire – Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company focused on bringing healthcare solutions to Canadians through licens...
(TheNewswire) VANCOUVER, BC. May 7, 2024 – TheNewswire – Aequus Pharmaceuticals Inc. (TSX-V: AQS , OTCQB: AQSZF ), ) (“Aequus” or the “Company”), a specialty pharmaceutical company, in resp...